Skip to main content

Table 2 Characteristics of sAMC patients and healthy controls

From: Abnormal T2 mapping cardiovascular magnetic resonance correlates with adverse clinical outcome in patients with suspected acute myocarditis

  controls sAMC p-value
n = 60 n = 46
Female (n) 17 (28%) 13 (28%) 0.993
Age (years) 43 ± 12 41 ± 16 0.783
   20–34 (n) 23 (38%) 17 (37%) 0.886
   35–49 (n) 23 (38%) 16 (35%) 0.710
    > 50 (n) 14 (23%) 13 (28%) 0.568
BMI (kg/m2) 24 ± 3 25 ± 4 0.819
Creatinine (mg/dl) n.a. 1.2 ± 1.9 n.a.
CMR Parameters
 LVEF % 62 ± 8 42 ± 15 <0.001
 LVEDVi (ml/m2) 75 ± 18 80 ± 19 0.084
 LVEDDi (ml/m2) 28±5 32±5 0.046
 Presence of LGE (n) 0 37 (80%) <0.001
 T2 Ratio > 1.9 (n) 7 (12%) 20 (43%) <0.001
 Global T2 Time (ms) 60.0 ± 4.2 68.1 ± 5.8 <0.001
 Fraction with T2 Time >80 ms (%) 4.1 ± 3.0 17.7 ± 11.5 <0.001
  1. Abbreviations: sAMC suspected acute myocarditis, BMI Body Mass Index, CMR Cardiovascular Magnetic Resonance, LVEF Left ventricular ejection fraction, LVEDVi Left Ventricular End Diastolic Volume index, LVEDDi Left Ventricular End Systolic Diameter index
  2. Values are mean ± standard deviation or percentage